Mireia Margelí

Mireia Margelí

UNVERIFIED PROFILE

Are you Mireia Margelí?   Register this Author

Register author
Mireia Margelí

Mireia Margelí

Publications by authors named "Mireia Margelí"

Are you Mireia Margelí?   Register this Author

25Publications

1038Reads

20Profile Views

Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer.

Int J Mol Sci 2018 Oct 19;19(10). Epub 2018 Oct 19.

Medical Oncology Department, B-ARGO Group, Institut Català d'Oncologia Badalona, Carretera del Canyet s/n, 08916 Badalona, Spain.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/19/10/3249
Publisher Site
http://dx.doi.org/10.3390/ijms19103249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214122PMC
October 2018

Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.

Chest 2017 Mar 1;151(3):564-571. Epub 2016 Nov 1.

Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol de Badalona, Barcelona, Universidad Católica de Murcia, Guadalupe, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.10.025DOI Listing
March 2017

Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.

J Natl Cancer Inst 2017 01 25;109(4). Epub 2017 Jan 25.

Affiliations of authors: Hospital Universitario Morales Meseguer-IMIB, Murcia, Spain (EGB, MIL, ACB, FAdlP); Universidad Católica San Antonio de Murcia (UCAM), Murcia, Spain (EGB); Hospital Universitario 12 de Octubre, Madrid, Spain (DC, RM); Instituto Nacional de Cancerología, Mexico DF, Mexico (NS, JLA); Hospital San Joan de Reus, IISSPV, URV, Spain (JG); Instituto de Investigación Sanitaria La Fe, Valencia, Spain (DH); Hospital Universitario La Fe, Valencia, Spain (JA); Investigación Clínica y Traslacional en Cáncer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain (ASM); Servicio de Oncología Médica, Hospital Clinic, IDIBAPS, Barcelona, Spain (BM); Hospital Clinico Lozano Blesa, Zaragoza, Spain (AS); Hospital Universitario Vall d'Hebron, Barcelona, Spain (CV); Complejo Hospitalario Universitario de Albacete, Albacete, Spain (AF); Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Spain (MM); Hospital Universitario Virgen del Rocío, Sevilla, Spain (ID); Hospital Central de Asturias, Oviedo, Spain (SF); Hospital Clínico San Carlos, Madrid, Spain (JS); Hospital Virgen de la Arrixaca, Murcia, Spain (SRo); Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (PM); Hospital Santa Lucía, Cartagena, Spain (PC); Hospital de Oncología, Centro Médico Nacional SXXI, México DF, México (SRi); Institut Catala d'Oncologia, Barcelona, Spain (XGdM, JRGL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw265DOI Listing
January 2017

Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.

J Clin Oncol 2015 Mar 17;33(9):1045-52. Epub 2015 Feb 17.

Miguel Martín, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense; Noelia Martinez, University Hospital Ramón y Cajal; José Ángel Garcia-Saenz, University Hospital Clínico San Carlos; Eva Carrasco, Grupo Español de Investigación en Cáncer de Mama, Madrid; Serafín Morales, Hospital Arnau de Vilanova de Lérida, Lérida; Angel Guerrero, Valencian Institute of Oncology, Valencia; Antonio Anton, University Hospital Miguel Servet, Zaragoza; Montserrat Muñoz, University Hospital Clinic i Provincial; Mireia Margeli, Hospital Universitario Germans Trias i Pujol, Barcelona; Miguel Gil, Catalan Institute of Oncology, Hospitalet; Manuel Ramos, Centro Oncológico de Galicia, La Coruña; Juan R. De la Haba-Rodriguez, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC) -Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, German Breast Group, Neu-Isenburg; Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, Sana Klinikum Offenbach, Offenbach; Bahriye Aktas, University Women's Hospital Essen, Essen; Winfried Schoenegg, Medical Practice Berlin, Berlin; Cornelia Liedtke, University Women's Hospital Münster, Münster; Cornelia Liedtke, University Hospital Lübeck, Lübeck; and Grischa Wachsmann, Klinikum Böblingen, Böblingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.2388DOI Listing
March 2015

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition.

Cancer Res 2014 Oct 8;74(19):5608-19. Epub 2014 Aug 8.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat; Barcelona, Spain. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-3659DOI Listing
October 2014

Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.

Breast 2013 Oct 15;22(5):908-13. Epub 2013 May 15.

Nuclear Medicine Department, Germans Trias i Pujol University Hospital, Carretera del Canyet, Badalona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.04.014DOI Listing
October 2013

Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study).

Clin Transl Oncol 2011 Apr;13(4):254-60

Department of Medical Oncology, Institut Català d’Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0650-9DOI Listing
April 2011

Current perspectives of treatment of ductal carcinoma in situ.

Cancer Treat Rev 2010 Nov 11;36(7):507-17. Epub 2010 May 11.

Centro Integral Oncológico Clara Campal, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2010.03.007DOI Listing
November 2010

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

PLoS One 2010 Mar 3;5(3):e9499. Epub 2010 Mar 3.

Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009499PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831058PMC
March 2010

Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.

Cancer Treat Rev 2008 Dec 14;34(8):701-9. Epub 2008 Oct 14.

Hospital Clinic i Provincial, Servicio de Oncología Médica, IDIBAPS, C/Villarroel, 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2008.04.002DOI Listing
December 2008